Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed Show 5 more changesShow less
    • Final enrollment: 149 participants (planned 90)
    • Primary completion date changed from estimate of Dec 2025 to Dec 22, 2025
    • Study completion date changed from estimate of Feb 2026 to Feb 20, 2026
    • Eligibility criteria shortened, about 44 words
    • Site details revised
  2. Minor Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
500 trials monitored
See 2 trials at risk
667 trials monitored
See 27 trials at risk
This study aims to investigate the association between the systemic immune-inflammation index and disease activity, as well as lupus nephritis in patients with systemic lupus erythematosus
Trial Details
NCT Number NCT06796569
Lead Sponsor Sohag University
Conditions
(from sponsor)
Systemic Lupus Erythematosus, Lupus Nephritis
Related terms Lupus Erythematosus, Systemic, Lupus Nephritis
Enrollment 149 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov